Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

FT sources: RBS' Hampton top contender to succeed Glaxo chair

A bribery scandal in China, with other probes ongoing in the Middle East and Europe. Mounting competition to declining top drug Advair. And so-far-lackluster launches of the products tabbed as future respiratory stars. So, who wants to be GlaxoSmithKline's next chairman?

Ex-Sanofi exec Whitaker takes the reins at Synta

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Exosome Diagnostics replaces CEO and relocates as it preps for commercialization

Exosome Diagnostics will advance its prostate cancer urine test to market with a new CEO and a change in locale to one of the biggest biotech clusters in the world.

Dendreon appoints ex-J&J exec as its new CEO

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Top Sanofi U.S. exec departs amid struggles in diabetes franchise

According to an internal memo obtained by The Wall Street Journal blog Pharmalot, Whitaker is leaving for "another opportunity."

J&J oncology vet takes the helm at foundering Dendreon

Struggling Dendreon has named a new CEO in W. Thomas Amick, a longtime Johnson & Johnson vet.

Ex-Pfizer exec Schulman lands at Polaris after an abrupt departure

Months after a swift exit from Pfizer's highest ranks, Amy Schulman has made her next move, joining high-profile biotech investor Polaris as a venture partner

Merck whacks 600 sales reps as part of 8,500 bloodletting

Merck is going through a complete makeover, buying and selling units at a rapid pace. And some of its employees are getting caught in its "out with the old and in with the new" philosophy. Now 600 sales reps have been told their services are no longer needed

Sarepta science officer Krieg 'terminated' quietly

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

News flash for biopharma bosses: More than half your employees want to leave

Biopharma employee looking for a new job? You're not alone. In fact, you're not even in the minority, a new report says.